Pharmacy & Therapeutics- August 2008 - (Page 487) CONTINUING EDUCATION CREDIT phylaxis of migraine: A double-blind, placebo-controlled study. Cephalagia 1996;16:436–440. 131. MacGregor EA, Frith A, Ellis J, et al. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006;67:2154–2163. 132. Allais G, Bussone G, De Lorenzo C, et al. Advanced strategies of short-term prophylaxis in menstrual migraine: State of the art and prospects. Neurol Sci 2005(Suppl 2):S125–S129. 133. Martin V, Brandes JL. Strategies for optimizing management of menstrual migraine. J Fam Pract 2005;54(12):S1–S7. 134. Silberstein SD, Armellino JJ, Hoffman HD, et al. Treatment of menstruation-associated migraine with the non-prescription combination of acetaminophen, aspirin, and caffeine: Results from three randomized, placebo-controlled studies. Clin Ther 1999; 21(3):475–491. 135. Sances G, Martignoni E, Fioroni L. Naproxen sodium in menstrual migraine prophylaxis: A double-blind placebo controlled study. Headache 1990;30(11):705–709. 136. Tepper SJ. Tailoring management strategies for the patient with menstrual migraine: Focus on prevention and treatment. Headache 2006;46(Suppl 2):S61–S68. 137. Newman LC, Lipton RB, Lay Cl, et al. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 1998;51:307–309. 138. Newman LC, Mannix LK, Landy S, et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: A randomized, double-blind, placebo-controlled study. Neurology 2000:54:14–21. 139. Brandes JL, Smith T, Diamond M, Ames MH. Open-label, longterm tolerability of naratriptan for short-term prevention of menstrually related migraine. Headache 2007;47:886–894. 140. Silberstein SD, Elkind AH, Schreiber C, et al. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 2004;63(2):261–269. 141. Silberstein SD. The role of sex hormones in headache. Neurology 1992;42(Suppl 2):37–42. 142. Silberstein SD, Merriam GR. Estrogens, progestins, and headache. Neurology 1991;41:786–793. 143. de Lignieres B, Vincens M, Mauvais-Jarvis P, et al. Prevention of menstrual migraine by percutaneous estradiol. Br Med J 1986;293: 1540–1546. 144. Lichten EM, Bennett RS, Whitty AJ, et al. Efficacy of danazol in the control of hormonal migraine. J Reprod Med 1991;36(6):419– 424. 145. O’Dea JP, Davis EH. Tamoxifen in the treatment of menstrual migraine. Neurology 1990;40:1470–1471. 146. Herzog AG. Continuous bromocriptine therapy in menstrual migraine. Neurology 1997;48:101–102. 147. Fox AW, Diamond ML, Spierings EL. Migraine during pregnancy: Options for therapy. CNS Drugs 2005;19(6):465–481. 148. Silberstein SD. Headaches in pregnancy. Neurol Clin 2004;(4): 727–756. 149. Marcus DA. Headache in pregnancy. Curr Pain Headache Rep 2003;7:288–296. 150. Kallen B, Lygner PE. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 2001;41:351–356. 151. Evans RW, Diamond ML. Expert opinion: Is sumatriptan use safe during pregnancy? Headache 2000;40:856–857. 152. Dey R, Khan S, Akhouri V, et al. Labetalol for prophylactic treatment of intractable migraine during pregnancy. Headache 2002; 42:642–645. 153. Lewis D, Ashwal S, Hershey A, et al. Practice parameter: Pharmacological treatment of migraine headache in children and adolescents: Report of the American Academy of Neurology Quality Standards Subcommittee and Practice Committee of the Child Neurology Society. Neurology 2004;63:2215–2224. 154. Hershey A, Scott WP, LeCates S, et al. Effectiveness of nasal sumatriptan in 5- to 12-year-old children. Headache 2001;41: 693– 697. 155. Lewis DW, Winner P, Hershey AD, et al. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 2007;120:390–396. 156. de Souza Carvalho D, Fragoso YD, Coelho FM, et al. Asthma plus migraine in childhood and adolescence: Prophylactic benefits with leukotriene receptor antagonist. Headache 2002;41:1044– 1047. 157. Wang F, Van Den Eden SK, Ackerson LM, et al. Oral magnesium oxide prophylaxis of frequent headaches in children: A randomized, double-blind, placebo-controlled trial. Headache 2004:44(5): 445–446. 158. Caruso JM, Brown WD, Exil G, et al. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 2000;40:672–676. 159. Pakalnis A, Greenberg G, Drake ME, et al. Pediatric migraine prophylaxis with divalproex. J Child Neurol 2001;16:731–734. 160. Bigal ME, Liberman JN, Lipton RB. Age-dependent prevalence and clinical features of migraine. Neurology 2006;67(2):246–251. 161. Sarchielli P, Mancini ML, Calabresi P. Practical considerations for the treatment of elderly patients with migraine. Drugs Aging 2006;23(6):461–489. 162. Martins KM, Bordini CA, Bigal ME, et al. Migraine in the elderly: A comparison with migraine in young adults. Headache 2006; 46(2):312–316. 163. Diener HC, Kaube H, Limmroth V. A practical guide to the management and prevention of migraine. Drugs 1998;56(5):811–824. 164. Evers S, Afra J, Frese A, et al. EFNS [European Federation of Neurological Societies] guideline on the drug treatment of migraine: Report of an EFNS Task Force. Eur J Neurol 2006;13:560–572. 165. Pryse-Phillips WE, Dodick DW, Edmeads JG, et al., for the Canadian Headache Society. Guidelines for the diagnosis and management of migraine in clinical practice Can Med Assoc J 1997;156: 1273–1287. 166. Lipton RB, Stewart WF, Stone AM, et al. Stratified care vs. step care strategies for migraine: The Disability in Strategies of Care (DISC) Study: A randomized trial. JAMA 2000;284(20):2599– 2605. I Conflict of Interest (COI) Statement Dr. DeMaagd has no relationships to disclose. This article contains discussions of off-label use. The content of this article has been reviewed under Jefferson’s Continuing Medical Education COI policy. Vol. 33 No. 8 • August 2008 • P&T® 487
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.